BNP PARIBAS FINANCIAL MARKETS - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 39 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2014$2,275,000
-32.5%
1,1430.0%0.00%
Q1 2014$3,372,000
-12.2%
1,1430.0%0.00%
Q4 2013$3,840,0001,1430.00%
Other shareholders
TRANSCEPT PHARMACEUTICALS IN shareholders Q1 2014
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 1,942,184$3,865,0004.53%
NEA Management Company, LLC 2,086,755$4,153,0000.20%
BVF INC/IL 150,000$299,0000.05%
ABNER HERRMAN & BROCK LLC 20,000$40,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 137,000$273,0000.01%
Spark Investment Management LLC 16,100$32,0000.01%
CSS LLC/IL 20,420$41,0000.00%
Waverly Advisors, LLC 2,670$5,0000.00%
PANAGORA ASSET MANAGEMENT INC 134,293$267,0000.00%
DIMENSIONAL FUND ADVISORS LP 466,573$928,0000.00%
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders